KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Accounts Payables (2016 - 2025)

Merck (MRK) has disclosed Accounts Payables for 17 consecutive years, with $4.4 billion as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 7.97% to $4.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 billion through Dec 2025, up 7.97% year-over-year, with the annual reading at $4.4 billion for FY2025, 7.97% up from the prior year.
  • Accounts Payables for Q4 2025 was $4.4 billion at Merck, up from $4.1 billion in the prior quarter.
  • The five-year high for Accounts Payables was $4.6 billion in Q4 2021, with the low at $3.4 billion in Q3 2021.
  • Average Accounts Payables over 5 years is $3.8 billion, with a median of $3.7 billion recorded in 2022.
  • The sharpest move saw Accounts Payables dropped 10.65% in 2022, then grew 15.64% in 2025.
  • Over 5 years, Accounts Payables stood at $4.6 billion in 2021, then decreased by 7.49% to $4.3 billion in 2022, then dropped by 8.02% to $3.9 billion in 2023, then rose by 4.0% to $4.1 billion in 2024, then increased by 7.97% to $4.4 billion in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $4.4 billion, $4.1 billion, and $3.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.